Article Information
History
- October 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yu-Pu Wu, MD, MSc1,*,
- Cheng-Kuan Lin, MD, ScD2,3,
- Rikuta Hamaya, MD, MSc1,
- Fei-Yang Huang, MD4,
- Yung-Shin Chien, MD, MSc5,
- Yu-Tien Hsu, MD, MPH6,
- Szu-Ta Chen, MD, PhD, MPH1 and
- Stefania Papatheodorou, MD, PhD1
- 1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.
- 2Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.
- 3School of Arts and Sciences, Massachusetts College of Pharmacy and Health Sciences, MA, U.S.A.
- 4Department of Physiology, Development and Neuroscience, University of Cambridge, United Kingdom
- 5Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, U.S.A.
- 6Population Health Sciences, Graduate School of Arts and Sciences, Harvard University, U.S.A.
- ↵*Corresponding author:
Yu-Pu Wu, yupuwu{at}hsph.harvard.edu; hiarpu{at}gmail.com, Mail address: 677 Huntington Ave., Boston, MA 02115, Phone: +1 857-205-2678
Posted October 18, 2021.
Intravenous corticosteroid treatment in adult patients with sepsis defined by the Sepsis-3 criteria: a systematic review and meta-analysis
